Narwhal Capital Management Trims Holdings in Abbott Laboratories (NYSE:ABT)
Narwhal Capital Management lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 25.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 23,208 shares of the healthcare product maker’s stock after selling 8,115 shares during the period. Narwhal Capital Management’s […]